🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the efficacy and safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01156792
Treatments Being Tested
A randomised, double-blind, placebo-controlled, parallel group study to eva...
Status
Terminated
Location
GSK Investigational Site
Start Date
2009-06-26
Trial ID
NCT00850642
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy and safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-12
Trial ID
NCT01248975
GSK2190915 is under development as an oral controller for the treatment of ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-11
Trial ID
NCT01286844
Treatments Being Tested
Leukotrienes are potent inflammatory molecules produced mainly by mast cell...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-01-06
Trial ID
NCT01411111
Treatments Being Tested
To evaluate the efficacy, dose response and safety of four doses of GSK2190...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-28
Trial ID
NCT01147744
GSK2190915 is a high affinity 5-lipoxygenase-activating protein (FLAP) inhi...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-30
Trial ID
NCT01318980
This study is a randomized, placebo controlled, four way crossover, in whic...
Status
Withdrawn
Location
GSK Investigational Site
Start Date
2010-09
Trial ID
NCT01721135
Treatments Being Tested
GSK2190915 is a high affinity 5-lipoxygenase-activating protein (FLAP) inhi...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-04-20
Trial ID
NCT02224521
The purpose of this study is to investigate the effect on repeat doses of G...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06
Trial ID
NCT01471665
Treatments Being Tested